IPP Bureau
Prof. Gobardhan Das appointed to NITI Aayog; PM Modi commends his contributions to R&D
By IPP Bureau - April 27, 2026
His appointment is expected to strengthen scientific input in policy discussions across public health, biotech, and translational research
Sun Pharma to acquire Organon in $11.75 billion all-cash deal
By IPP Bureau - April 27, 2026
Acquisition to expand the company's women’s health and biosimilars footprint, positioning it among top 25 drugmakers globally
Alembic announces FDA final approval for Fingolimod capsules
By IPP Bureau - April 27, 2026
The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Gilenya Capsules, 0.5 mg of Novartis Pharmaceuticals Corporation (Novartis)
Nihilent unveils nSEPIA Beta to turn emotional wellness into measurable science
By IPP Bureau - April 27, 2026
nSEPIA aims to bring structure to an area long dominated by subjectivity
BMS–Pfizer expands Eliquis access through Cost Plus Drug setting $345 monthly price
By IPP Bureau - April 27, 2026
The move brings one of the country’s most widely prescribed blood thinners onto Cost Plus Drug Company’s online pharmacy platform
Zydus wins DCGI nod to launch Phase III trials of new anti-malarial drug Zintrodiazine
By IPP Bureau - April 27, 2026
The first Phase III and second Phase III trials will be multi-centre, randomised, assessor-blind, active-comparator studies to determine the efficacy, safety and tolerability of orally administered Zintrodiazine
.jpg "Cipla wins USFDA nod for first generic of Ventolin HFA strengthening respiratory push")
Cipla wins USFDA nod for first generic of Ventolin HFA strengthening respiratory push
By IPP Bureau - April 27, 2026
The approval makes Cipla’s product the first AB-rated generic therapeutic equivalent of Ventolin HFA
Huwel Lifesciences, ASMS expand into Southeast Asia with Singapore partner
By IPP Bureau - April 27, 2026
Collaboration to drive diagnostics exports, tap high-growth regional markets and build scalable commercialization platform
Mandeep Singh Kumar, Shankha Banerjee join NATHEALTH leadership team
By IPP Bureau - April 27, 2026
New appointments bring diagnostics and medtech expertise to strengthen healthcare delivery and policy engagement
Maarga Mind Care launches integrative day care program to bridge mental health recovery gap
By IPP Bureau - April 27, 2026
New model focuses on continuity of care, combining therapy, routine and social engagement to support long-term recovery
.png "Tata AIA launches ‘Shubh Health Criti’ blending life cover with wellness and investments"){kind=logo}
Tata AIA launches ‘Shubh Health Criti’ blending life cover with wellness and investments
By IPP Bureau - April 27, 2026
New plan integrates critical illness protection, market-linked health fund and preventive care platform for holistic financial and health security
NIT Rourkela secures patent for rapid spice adulteration detection system
By IPP Bureau - April 27, 2026
FTIR and machine learning-based technology enables real-time, cost-effective quantification of food adulterants
Raay Neo Pharma launches operations to expand access to quality healthcare across India
By IPP Bureau - April 27, 2026
Founded by Amit Patni, the company rolls out 90+ formulations across acute and specialty therapies
Umang Vohra appointed Executive Chairman and Group CEO of Cohance Lifesciences
By IPP Bureau - April 27, 2026
Former Cipla MD & CEO to lead next phase of growth at science-led CDMO platform; Vivek Sharma transitions to advisory role
Metropolis Healthcare launches blood-based test for early Alzheimer’s detection
By IPP Bureau - April 27, 2026
New minimally invasive biomarker test enables earlier diagnosis and improved clinical decision-making, aligned with global guidelines
